CytoSorbents postpones earnings release to allow time for annual audit

CytoSorbents (CTSO) announced that it is postponing its previously announced earnings call scheduled for March 6, 2025 to allow more time to complete the annual financial audit following the recent passing of the Company’s Vice President and Corporate Controller from natural causes. The Company now expects to report fourth quarter and full year 2024 financial results after the market close on Tuesday, March 25, 2025. Management will host a live conference call, presentation webcast, and a question-and-answer session starting at 4:30PM ET the same day, and expects to file its Form 10-K in that timeframe. The delay follows the unexpected passing of the Company’s Vice President and Corporate Controller, James E. Cason, Jr.